US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 43.670
  • +0.370+0.85%
Trading May 2 15:22 ET
3.63BMarket Cap-5293P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-24.80%-474.81M
7.13%-83.9M
-23.63%-117.87M
-50.36%-116.16M
-33.48%-156.87M
-12.33%-380.47M
-66.24%-90.34M
-59.84%-95.35M
-18.21%-77.26M
26.25%-117.52M
Net income from continuing operations
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
-29.19%-158.16M
-11.88%-152.32M
Depreciation and amortization
42.73%26.01M
65.79%8.22M
53.20%7.19M
19.64%5.36M
28.08%5.24M
37.62%18.22M
40.27%4.96M
45.91%4.69M
43.58%4.48M
21.41%4.09M
Other non cash items
-101.10%-1.06M
-214.99%-10.14M
-102.17%-1.83M
-102.76%-27K
514.32%10.94M
721.17%96.13M
877.18%8.82M
2,037.11%84.54M
-75.59%980K
-63.44%1.78M
Change In working capital
-125.07%-15.1M
-39.11%13.3M
-87.37%2.8M
-74.35%7.16M
-228.21%-38.36M
195.25%60.24M
5.60%21.85M
614.57%22.17M
385.64%27.91M
84.87%-11.69M
-Change in receivables
-88.75%-22.78M
111.13%1.01M
-204.64%-6.2M
-68.75%-15.08M
-7,700.00%-2.51M
-122.16%-12.07M
-196.25%-9.1M
955.56%5.93M
-2,857.72%-8.94M
101.66%33K
-Change in inventory
28.56%-6.93M
53.48%-1.96M
-338.31%-3.47M
48.70%-1.66M
110.17%150K
-211.23%-9.7M
-324.75%-4.21M
-1,782.98%-791K
-21.98%-3.23M
-411.18%-1.48M
-Change in prepaid assets
303.50%15.33M
-138.86%-1.26M
-32.12%4.99M
176.09%12.11M
-105.69%-519K
112.87%3.8M
114.38%3.24M
263.37%7.35M
-1,062.45%-15.92M
185.64%9.13M
-Change in payables and accrued expense
-97.28%2.38M
-51.10%17.13M
-32.94%7.48M
-79.48%11.78M
-110.39%-34.01M
170.61%87.44M
15.24%35.03M
-17.03%11.16M
375.52%57.42M
31.51%-16.16M
-Change in other working capital
66.46%-3.1M
48.08%-1.62M
--0
--0
53.91%-1.48M
83.94%-9.24M
-118.47%-3.12M
87.38%-1.48M
93.25%-1.43M
92.26%-3.21M
Cash from discontinued investing activities
Operating cash flow
-24.80%-474.81M
7.13%-83.9M
-23.63%-117.87M
-50.36%-116.16M
-33.48%-156.87M
-12.33%-380.47M
-66.24%-90.34M
-59.84%-95.35M
-18.21%-77.26M
26.25%-117.52M
Investing cash flow
Cash flow from continuing investing activities
157.60%168M
37.64%-107.02M
139.72%64.3M
25.58%99.42M
397.91%111.3M
-49.28%-291.65M
-348.49%-171.6M
-297.11%-161.86M
291.94%79.17M
79.52%-37.36M
Net PPE purchase and sale
61.88%-44.27M
94.07%-1.6M
85.81%-3.7M
54.93%-13.94M
22.22%-25.03M
-58.87%-116.12M
-68.06%-26.97M
-26.68%-26.05M
-54.07%-30.92M
-96.08%-32.18M
Net intangibles purchase and sale
91.67%-2.5M
--0
--0
---2.5M
--0
---30M
--0
--0
--0
---30M
Net business purchase and sale
--0
--0
----
----
----
---75.03M
--366K
----
----
----
Net investment purchase and sale
415.55%219.82M
27.18%-105.15M
213.57%68.42M
5.42%116.25M
467.93%140.29M
42.59%-69.66M
-268.76%-144.39M
-205.63%-60.25M
620.77%110.27M
114.88%24.7M
Net other investing changes
-498.10%-5.05M
55.13%-271K
-141.81%-428K
-117.49%-398K
-3,392.50%-3.95M
10.40%-844K
-32.75%-604K
---177K
---183K
--120K
Cash from discontinued investing activities
Investing cash flow
157.60%168M
37.64%-107.02M
139.72%64.3M
25.58%99.42M
397.91%111.3M
-49.28%-291.65M
-348.49%-171.6M
-297.11%-161.86M
291.94%79.17M
79.52%-37.36M
Financing cash flow
Cash flow from continuing financing activities
-22.56%388.14M
17,466.95%330.61M
-94.87%25.23M
465.70%33.02M
-144.79%-722K
322.77%501.21M
-97.80%1.88M
6,414.93%491.88M
-53.78%5.84M
-87.26%1.61M
Net common stock issuance
--379.76M
--326.46M
--24.79M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
-22.18%8.42M
107.60%4.15M
-58.85%442K
-23.63%4.57M
-142.74%-750K
-73.04%10.81M
-71.10%2M
-86.00%1.07M
-53.05%5.98M
-86.25%1.76M
Net other financing activities
-100.01%-28K
--0
--0
61.64%-56K
119.58%28K
99,773.78%490.4M
16.20%-119K
395,908.87%490.8M
-28.07%-146K
-27.68%-143K
Cash from discontinued financing activities
Financing cash flow
-22.56%388.14M
17,466.95%330.61M
-94.87%25.23M
465.70%33.02M
-144.79%-722K
322.77%501.21M
-97.80%1.88M
6,414.93%491.88M
-53.78%5.84M
-87.26%1.61M
Net cash flow
Beginning cash position
-55.55%137.6M
-80.17%78.61M
-33.83%107.67M
-41.41%91.53M
-55.55%137.6M
-57.37%309.59M
89.13%396.31M
-46.28%162.72M
-60.59%156.21M
-57.37%309.59M
Current changes in cash
147.59%81.34M
153.71%139.69M
-112.08%-28.35M
110.08%16.28M
69.80%-46.29M
58.87%-170.91M
-358.92%-260.06M
352.72%234.67M
108.24%7.75M
53.43%-153.27M
Effect of exchange rate changes
142.98%462K
-18.42%1.1M
33.77%-716K
89.01%-136K
295.37%211K
9.97%-1.08M
444.90%1.35M
-125.68%-1.08M
-376.34%-1.24M
85.99%-108K
End cash Position
59.45%219.4M
59.45%219.4M
-80.17%78.61M
-33.83%107.67M
-41.41%91.53M
-55.55%137.6M
-55.55%137.6M
89.13%396.31M
-46.28%162.72M
-60.59%156.21M
Free cash flow
0.95%-521.57M
27.11%-85.5M
-0.15%-121.57M
-22.57%-132.6M
-1.22%-181.9M
-27.88%-526.59M
-66.66%-117.31M
-51.34%-121.39M
-26.63%-108.18M
-2.24%-179.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -24.80%-474.81M7.13%-83.9M-23.63%-117.87M-50.36%-116.16M-33.48%-156.87M-12.33%-380.47M-66.24%-90.34M-59.84%-95.35M-18.21%-77.26M26.25%-117.52M
Net income from continuing operations 14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M-29.19%-158.16M-11.88%-152.32M
Depreciation and amortization 42.73%26.01M65.79%8.22M53.20%7.19M19.64%5.36M28.08%5.24M37.62%18.22M40.27%4.96M45.91%4.69M43.58%4.48M21.41%4.09M
Other non cash items -101.10%-1.06M-214.99%-10.14M-102.17%-1.83M-102.76%-27K514.32%10.94M721.17%96.13M877.18%8.82M2,037.11%84.54M-75.59%980K-63.44%1.78M
Change In working capital -125.07%-15.1M-39.11%13.3M-87.37%2.8M-74.35%7.16M-228.21%-38.36M195.25%60.24M5.60%21.85M614.57%22.17M385.64%27.91M84.87%-11.69M
-Change in receivables -88.75%-22.78M111.13%1.01M-204.64%-6.2M-68.75%-15.08M-7,700.00%-2.51M-122.16%-12.07M-196.25%-9.1M955.56%5.93M-2,857.72%-8.94M101.66%33K
-Change in inventory 28.56%-6.93M53.48%-1.96M-338.31%-3.47M48.70%-1.66M110.17%150K-211.23%-9.7M-324.75%-4.21M-1,782.98%-791K-21.98%-3.23M-411.18%-1.48M
-Change in prepaid assets 303.50%15.33M-138.86%-1.26M-32.12%4.99M176.09%12.11M-105.69%-519K112.87%3.8M114.38%3.24M263.37%7.35M-1,062.45%-15.92M185.64%9.13M
-Change in payables and accrued expense -97.28%2.38M-51.10%17.13M-32.94%7.48M-79.48%11.78M-110.39%-34.01M170.61%87.44M15.24%35.03M-17.03%11.16M375.52%57.42M31.51%-16.16M
-Change in other working capital 66.46%-3.1M48.08%-1.62M--0--053.91%-1.48M83.94%-9.24M-118.47%-3.12M87.38%-1.48M93.25%-1.43M92.26%-3.21M
Cash from discontinued investing activities
Operating cash flow -24.80%-474.81M7.13%-83.9M-23.63%-117.87M-50.36%-116.16M-33.48%-156.87M-12.33%-380.47M-66.24%-90.34M-59.84%-95.35M-18.21%-77.26M26.25%-117.52M
Investing cash flow
Cash flow from continuing investing activities 157.60%168M37.64%-107.02M139.72%64.3M25.58%99.42M397.91%111.3M-49.28%-291.65M-348.49%-171.6M-297.11%-161.86M291.94%79.17M79.52%-37.36M
Net PPE purchase and sale 61.88%-44.27M94.07%-1.6M85.81%-3.7M54.93%-13.94M22.22%-25.03M-58.87%-116.12M-68.06%-26.97M-26.68%-26.05M-54.07%-30.92M-96.08%-32.18M
Net intangibles purchase and sale 91.67%-2.5M--0--0---2.5M--0---30M--0--0--0---30M
Net business purchase and sale --0--0---------------75.03M--366K------------
Net investment purchase and sale 415.55%219.82M27.18%-105.15M213.57%68.42M5.42%116.25M467.93%140.29M42.59%-69.66M-268.76%-144.39M-205.63%-60.25M620.77%110.27M114.88%24.7M
Net other investing changes -498.10%-5.05M55.13%-271K-141.81%-428K-117.49%-398K-3,392.50%-3.95M10.40%-844K-32.75%-604K---177K---183K--120K
Cash from discontinued investing activities
Investing cash flow 157.60%168M37.64%-107.02M139.72%64.3M25.58%99.42M397.91%111.3M-49.28%-291.65M-348.49%-171.6M-297.11%-161.86M291.94%79.17M79.52%-37.36M
Financing cash flow
Cash flow from continuing financing activities -22.56%388.14M17,466.95%330.61M-94.87%25.23M465.70%33.02M-144.79%-722K322.77%501.21M-97.80%1.88M6,414.93%491.88M-53.78%5.84M-87.26%1.61M
Net common stock issuance --379.76M--326.46M--24.79M----------0--0--0--------
Proceeds from stock option exercised by employees -22.18%8.42M107.60%4.15M-58.85%442K-23.63%4.57M-142.74%-750K-73.04%10.81M-71.10%2M-86.00%1.07M-53.05%5.98M-86.25%1.76M
Net other financing activities -100.01%-28K--0--061.64%-56K119.58%28K99,773.78%490.4M16.20%-119K395,908.87%490.8M-28.07%-146K-27.68%-143K
Cash from discontinued financing activities
Financing cash flow -22.56%388.14M17,466.95%330.61M-94.87%25.23M465.70%33.02M-144.79%-722K322.77%501.21M-97.80%1.88M6,414.93%491.88M-53.78%5.84M-87.26%1.61M
Net cash flow
Beginning cash position -55.55%137.6M-80.17%78.61M-33.83%107.67M-41.41%91.53M-55.55%137.6M-57.37%309.59M89.13%396.31M-46.28%162.72M-60.59%156.21M-57.37%309.59M
Current changes in cash 147.59%81.34M153.71%139.69M-112.08%-28.35M110.08%16.28M69.80%-46.29M58.87%-170.91M-358.92%-260.06M352.72%234.67M108.24%7.75M53.43%-153.27M
Effect of exchange rate changes 142.98%462K-18.42%1.1M33.77%-716K89.01%-136K295.37%211K9.97%-1.08M444.90%1.35M-125.68%-1.08M-376.34%-1.24M85.99%-108K
End cash Position 59.45%219.4M59.45%219.4M-80.17%78.61M-33.83%107.67M-41.41%91.53M-55.55%137.6M-55.55%137.6M89.13%396.31M-46.28%162.72M-60.59%156.21M
Free cash flow 0.95%-521.57M27.11%-85.5M-0.15%-121.57M-22.57%-132.6M-1.22%-181.9M-27.88%-526.59M-66.66%-117.31M-51.34%-121.39M-26.63%-108.18M-2.24%-179.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg